|
SCAMP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.694400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.402100E-02 |
| Normal-vs-Stage2 |
5.626400E-01 |
| Normal-vs-Stage3 |
4.953600E-02 |
| Normal-vs-Stage4 |
1.682660E-03 |
| Stage1-vs-Stage2 |
2.340800E-01 |
| Stage1-vs-Stage3 |
8.398000E-01 |
| Stage1-vs-Stage4 |
3.824300E-02 |
| Stage2-vs-Stage3 |
2.527600E-01 |
| Stage2-vs-Stage4 |
2.662100E-02 |
| Stage3-vs-Stage4 |
1.063430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.640200E-02 |
| Normal-vs-AfricanAmerican |
4.655600E-01 |
| Normal-vs-Asian |
1.024790E-03 |
| Caucasian-vs-AfricanAmerican |
4.976000E-01 |
| Caucasian-vs-Asian |
2.666200E-02 |
| AfricanAmerican-vs-Asian |
9.674300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.441600E-02 |
| Normal-vs-Female |
4.205700E-02 |
| Male-vs-Female |
5.349600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.837700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.401800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.031700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.828600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.425400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.697400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.448800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.988000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.587800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.820000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.265960E-01 |
| Classical-VS-Follicular |
3.511000E-01 |
| Classical-VS-Other |
4.554000E-01 |
| Classical-VS-Normal |
1.209040E-01 |
| Tall-VS-Follicular |
5.543000E-01 |
| Tall-VS-Other |
8.902400E-01 |
| Tall-VS-Normal |
2.290100E-02 |
| Follicular-VS-Other |
6.669000E-01 |
| Follicular-VS-Normal |
5.299900E-02 |
| Other-VS-Normal |
2.008000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.886400E-02 |
| Normal-vs-N1 |
7.363000E-03 |
| N0-vs-N1 |
2.362400E-01 |
|
|
